More than other NAD+ biosynthetic enzymes, Nampt and Nmnat2 are especially important to neurons and having both affected in ALS patient spinal cords indicates that the activity of the NAD+ salvage pathway may be an important target for treating ALS. This evidence concerns the gene NMNAT2 and amyotrophic lateral sclerosis.